Werlinich Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$653K Hold
3,080
0.25% 52
2026
Q1
$604K Buy
3,080
+50
+2% +$9.71K 0.29% 51
2025
Q4
$532K Buy
3,030
+120
+4% +$21.9K 0.26% 53
2025
Q3
$555K Hold
2,910
0.28% 54
2025
Q2
$523K Sell
2,910
-500
-15% -$86.8K 0.29% 53
2025
Q1
$577K Hold
3,410
0.37% 53
2024
Q4
$515K Sell
3,410
-345
-9% -$53.7K 0.3% 52
2024
Q3
$583K Hold
3,755
0.34% 52
2024
Q2
$516K Sell
3,755
-150
-4% -$20.5K 0.32% 50
2024
Q1
$512K Sell
3,905
-2,910
-43% -$378K 0.33% 51
2023
Q4
$938K Sell
6,815
-339
-5% -$44.6K 0.71% 36
2023
Q3
$872K Buy
7,154
+164
+2% +$21.9K 0.72% 35
2023
Q2
$983K Hold
6,990
0.79% 33
2023
Q1
$989K Buy
6,990
+10
+0.1% +$1.43K 0.87% 32
2022
Q4
$1.09M Sell
6,980
-85
-1% -$12.2K 1.01% 30
2022
Q3
$867K Sell
7,065
-100
-1% -$13.2K 0.89% 32
2022
Q2
$953K Sell
7,165
-525
-7% -$71.5K 0.89% 32
2022
Q1
$1.05M Sell
7,690
-245
-3% -$34.1K 0.8% 37
2021
Q4
$1.37M Hold
7,935
1% 34
2021
Q3
$1.15M Sell
7,935
-110
-1% -$16.1K 0.93% 35
2021
Q2
$1.06M Hold
8,045
0.86% 39
2021
Q1
$1.03M Buy
+8,045
New +$991K 0.91% 39

Other funds holding DGX

Werlinich Asset Management's DGX Position: Q2 2026 in Review

Werlinich Asset Management held its Quest Diagnostics (DGX) position steady in Q2 2026 at 3,080 shares worth $653K. The position accounts for 0.25% of the portfolio, ranked #52.

Werlinich Asset Management first reported a position in DGX in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.37M in Q4 2021. 210 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Werlinich Asset Management held 3,080 shares of Quest Diagnostics worth $653K as of Q2 2026.
  • Werlinich Asset Management left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up 0.25% of Werlinich Asset Management's portfolio in Q2 2026, its #52 holding.
  • Werlinich Asset Management first reported a position in Quest Diagnostics in Q1 2021 and has held it in 22 quarters since.
  • Werlinich Asset Management's Quest Diagnostics position peaked at $1.37M in Q4 2021.
  • 210 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Werlinich Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.